Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients

Citation
K. Lietz et al., Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients, CIRCULATION, 104(12), 2001, pp. I177-I183
Citations number
34
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
104
Issue
12
Year of publication
2001
Supplement
S
Pages
I177 - I183
Database
ISI
SICI code
0009-7322(20010918)104:12<I177:IPOAPA>2.0.ZU;2-4
Abstract
Background-The influence of sex on alloreactivity and graft outcome after h eart transplantation was evaluated. Methods and Results-A retrospective review of 520 consecutive recipients of a primary cardiac allograft between 1992 and 2000 at a single center was p erformed. The influence of sex on alloreactivity, acute rejection, transpla nt-related coronary artery disease, and survival was determined. Statistica l methods included logistic regression analysis and Kaplan-Meier actuarial survival analysis. Female recipients had an increased prevalence before tra nsplant of idiopathic cardiomyopathy, antinuclear antibodies, and HLA-138, DR3 haplotypes. After transplant, female sex predicted shorter duration to a first rejection, higher cumulative rejection frequency, and earlier postt ransplant production of anti-HLA antibodies. Female recipients had higher e arly mortality rates (<6 months) that were due to infection. Fatal infectio ns correlated with 2-fold higher cyclosporine levels in female recipients. However, the incidence of transplant-related coronary artery disease develo ping beyond I year after transplant was lower in female than in male recipi ents. Conclusions-Females undergoing cardiac transplantation are more likely to m anifest features of an underlying autoimmune state. This may predispose to a higher posttransplant risk of allograft rejection and requirement for inc reased immunosuppression. Earlier diagnosis and management of alloreactivit y in female recipients before development of acute rejection and the use of more focused and less globally immunosuppressive agents during established rejections may have a significant effect on the clinical outcome of female cardiac allograft recipients.